| Literature DB >> 29218040 |
Wenyi Zhang1, Huiling Guo1, Chenxia Cao1, Lina Li1, Lai-Yu Kwok1, Heping Zhang1, Zhihong Sun1.
Abstract
Lactobacillus (L. casei) Zhang is a koumiss-originated probiotic strain, which was used as a model in a long-term antibiotics-driven evolution experiment to reveal bacterial evolutionary dynamics; and we isolated gentamycin-resistant L. casei Zhang descendents. To decipher the gentamycin resistance mechanism, here we cultivated the parental L. casei Zhang and its descendent cells in an antibiotics-containing environment to compare their global protein expression profiles using the iTRAQ-based proteomic approach. A total of 72 proteins were significantly up-regulated (>2.0-fold, P < 0.05), whilst 32 proteins were significantly down-regulated <-2.0-fold, P < 0.05) in the descendent line. The gentamycin-resistant descendent line showed elevated expression in some carbohydrates, amino acids, and purine metabolic pathways. Several stress-related proteins were also differentially expressed. Among them, one alkaline shock protein, asp23, was up-regulated most in the gentamycin-resistant strain (21.9-fold increase compared with the parental strain). The asp23 gene disruption mutant was significantly more sensitive to gentamycin compared with the wild type, suggesting an important role of this gene in developing the gentamycin-resistant phenotype in L. casei. Our report has described the adaptation of a probiotic strain that has acquired antibiotics resistance through long-term antibiotics exposure at the proteome level, and we revealed a novel mechanism of gentamycin resistance.Entities:
Keywords: Lactobacillus casei Zhang; alkaline shock protein; asp23; gentamycin; proteomic analysis
Year: 2017 PMID: 29218040 PMCID: PMC5703869 DOI: 10.3389/fmicb.2017.02316
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Strains, primers, and plasmids used for constructing the gene disruption mutant.
| Cloning host | This study | |
| Isolated from home-made koumiss in Inner Mongolia, China | Wu et al., | |
| Wang et al., | ||
| Derivative of | This study | |
| Derivative of | This study | |
| pNZ5319 | CmrEmr; containing | Lambert et al., |
| pNZ5319-0227Up-Down | CmrEmr; pNZ5319 derivative containing homologous regions upstream and downstream of LCAZH_0227 | This study |
| pMSPcre | Emr; expression of | Unpublished |
| 0227upF | 5′-ACGC | This study |
| 0227upR | 5′-AGCTTT | This study |
| 0227downF | 5′-GGGTTT | This study |
| 0227downR | 5′-GA | This study |
| 85 | 5′-GTTTTTTTCTAGTCCAAGCTCACA-3′ | Lambert et al., |
| 87 | 5′-GCCGACTGTACTTTCGGATCCT-3′ | Lambert et al., |
| CatF | 5′-TCAAATACAGCTTTTAGAACTGG-3′ | Lambert et al., |
| CatR | 5′-ACCATCAAAAATTGTATAAAGTGGC-3′ | Lambert et al., |
| EryintF | 5′-CGATACCGTTTACGAAATTGG-3′ | Lambert et al., |
| EryintR | 5′-CTTGCTCATAAGTAACGGTAC-3′ | Lambert et al., |
The restriction sites in the primer sequences are underlined.
Figure 1Growth curves of the parental and L. casei Zhang-G-1200 strains based on viable counts (A), pH values (B) and OD values (C) in gentamycin-containing LSM.
Up-regulated proteins of L. casei Zhang-G-1200 compared with its original strain in the presence of the gentamycin.
| LCAZH_0394 | Hypothetical protein | 2.07 |
| LCAZH_0395 | Mannose-6-phosphate isomerase | 3.06 |
| LCAZH_0403 | PTS system mannose/fructose/N-acetylgalactosamine-specific transporter subunit IIB | 2.23 |
| LCAZH_0503 | Sugar phosphate isomerase/epimerase | 2.19 |
| LCAZH_0604 | PTS system galactitol-specific transporter subunit IIB | 2.1 |
| LCAZH_0605 | PTS system galacitol transporter subunit EIIC | 2.22 |
| LCAZH_1336 | Tagatose-6-phosphate kinase | 2.41 |
| LCAZH_1768 | Beta-glucosidase/6-phospho-beta-glucosidase/beta-galactosidase | 2.13 |
| LCAZH_1771 | PTS system cellobiose-specific transporter subunit IIA | 2.2 |
| LCAZH_1772 | PTS system cellobiose-specific transporter subunit IIB | 2.61 |
| LCAZH_2151 | beta-glucosidase/6-phospho-beta-glucosidase/beta-galactosidase | 2.14 |
| LCAZH_2624 | PTS system fructose-specific transporter subunit IIB | 2.36 |
| LCAZH_2633 | PTS system galactitol transporter subunit IIB | 2.97 |
| LCAZH_2645 | Hypothetical protein | 2.53 |
| LCAZH_2648 | PTS system galacitol transporter subunit EIIB | 5.79 |
| LCAZH_2649 | PTS system galacitol transporter subunit EIIA | 3.96 |
| LCAZH_2653 | Trehalose-6-phosphate hydrolase | 4.66 |
| LCAZH_2725 | Transaldolase | 4.56 |
| LCAZH_2895 | PTS system mannitol-specific transporter subunit IIBC | 3.96 |
| LCAZH_0084 | Tryptophan synthase subunit alpha | 2.25 |
| LCAZH_0107 | Tetrahydrodipicolinate N-succinyltransferase | 2.25 |
| LCAZH_0201 | Oligopeptide ABC transporter periplasmic protein | 2.04 |
| LCAZH_0418 | Amino acid ABC transporter ATP-binding protein | 2.14 |
| LCAZH_0500 | Amino acid transporter | 2.59 |
| LCAZH_0506 | Shikimate 5-dehydrogenase | 2.08 |
| LCAZH_1596 | Oligopeptide ABC transporter periplasmic protein | 2.47 |
| LCAZH_1682 | Lactoylglutathione lyase-like lyase | 2.22 |
| LCAZH_1886 | Oligopeptide ABC transporter periplasmic protein | 2.92 |
| LCAZH_1980 | Branched-chain amino acid aminotransferase/4-amino-4-deoxychorismate lyase | 2.04 |
| LCAZH_2023 | Dipeptide/oligopeptide/nickel ABC transporter ATPase | 2.21 |
| LCAZH_2024 | Dipeptide/oligopeptide/nickel ABC transporter permease | 2.45 |
| LCAZH_2025 | Dipeptide/oligopeptide/nickel ABC transporter permease | 3.27 |
| LCAZH_2026 | Oligopeptide ABC transporter periplasmic protein | 2.68 |
| LCAZH_2111 | Homoserine dehydrogenase | 2.36 |
| LCAZH_2302 | Aminopeptidase | 6.77 |
| LCAZH_2518 | NADPH-dependent glutamate synthase subunit beta-like oxidoreductase | 3.52 |
| LCAZH_2519 | Glutamate synthase domain 3 | 2.54 |
| LCAZH_2851 | Polar amino acid ABC transporter ATPase | 2.23 |
| LCAZH_0188 | Acetate kinase | 2.17 |
| LCAZH_1301 | Acetoin/pyruvate dehydrogenase complex, E2 component, dihydrolipoamide succinyltransferase | 2.05 |
| LCAZH_1302 | Acetoin/pyruvate dehydrogenase complex, E3 component, dihydrolipoamide dehydrogenase | 2.13 |
| LCAZH_1396 | Pyruvate-formate lyase | 3.75 |
| LCAZH_2375 | Fumarase | 2.1 |
| LCAZH_1739 | Folate-dependent phosphoribosylglycinamide formyltransferase PurN | 2.5 |
| LCAZH_1740 | Phosphoribosylaminoimidazole (AIR) synthetase | 2.23 |
| LCAZH_1743 | Phosphoribosylformylglycinamidine (FGAM) synthase, glutamine amidotransferase domain | 2.21 |
| LCAZH_0447 | Conjugated bile salt hydrolase-like amidase | 5.04 |
| LCAZH_1410 | GNAT family acetyltransferase | 2.42 |
| LCAZH_2210 | Transcriptional regulator | 3.18 |
| LCAZH_1463 | Lipoate-protein ligase A | 2.05 |
| LCAZH_1880 | Acetyltransferase | 3.78 |
| LCAZH_0279 | ADP-ribosylglycohydrolase | 2.51 |
| LCAZH_1344 | Chaperone ClpB | 3.68 |
| LCAZH_1380 | Peptide methionine sulfoxide reductase | 2.23 |
| LCAZH_1398 | Pyruvate-formate lyase-activating enzyme | 2.88 |
| LCAZH_1217 | Multidrug ABC transporter ATPase | 6.01 |
| LCAZH_0294 | Alpha/beta hydrolase | 2.64 |
| LCAZH_0305 | NAD(FAD)-dependent dehydrogenase | 2.14 |
| LCAZH_0638 | ABC transporter periplasmic protein | 2.06 |
| LCAZH_0641 | ABC transporter permease | 2.3 |
| LCAZH_0642 | ABC transporter ATPase | 2.15 |
| LCAZH_1865 | Dinucleotide-binding enzyme | 2.05 |
| LCAZH_2372 | Oxidoreductase | 2.53 |
| LCAZH_2373 | Short-chain alcohol dehydrogenase | 3.71 |
| LCAZH_0227 | Alkaline shock protein | 21.93 |
| LCAZH_2030 | Hypothetical protein | 3.57 |
| LCAZH_2301 | Putative integral membrane protein | 3.32 |
| LCAZH_2056 | Hypothetical protein | 2.3 |
| LCAZH_2222 | Hypothetical protein | 3.29 |
| LCAZH_1464 | Hypothetical protein | 3.26 |
| LCAZH_1898 | Hypothetical protein | 2.42 |
| LCAZH_0186 | Hypothetical protein | 2.34 |
Figure 2Proteomic profiles of differentially expressed proteins of the parental L. casei Zhang G-0 and gentamycin-resistant L. casei Zhang-G-1200 strains. Clusters of orthologous groups (COG) functional categories: [C], Energy production and conversion; [E], Amino acid transport and metabolism; [F] Nucleotide transport and metabolism; [G], Carbohydrate transport and metabolism; [H], Coenzyme transport and metabolism; [I], Lipid transport and metabolism; [J], Translation, ribosomal structure and biogenesis; [K], Transcription; [L], Replication, recombination and repair; [M], Cell wall/membrane/envelope biogenesis; [O], Posttranslational modification, protein turnover, chaperones; [P], Inorganic ion transport and metabolism; [Q], Secondary metabolites biosynthesis, transport and catabolism; [R], General function prediction only; [S], Function unknown; [T], Signal transduction mechanisms; [V], Defense mechanisms.
Down-regulated proteins of L. casei Zhang-G-1200 compared with its original strain in the presence of the gentamycin.
| LCAZH_2698 | Fructose/tagatose bisphosphate aldolase | −3.3 |
| LCAZH_1424 | Histidinol-phosphate/aromatic aminotransferase and cobyric acid decarboxylase | −2.51 |
| LCAZH_0738 | D-alanyl transfer protein | −2.1 |
| LCAZH_2870 | Glycosyltransferase | −2.22 |
| LCAZH_1554 | Transcriptional regulator | −2.06 |
| LCAZH_0497 | Membrane associated subtilisin-like serine protease | −2.77 |
| LCAZH_0907 | Protease subunit of ATP-dependent Clp protease | −2.04 |
| LCAZH_1553 | Molecular chaperone GrpE | −2.09 |
| LCAZH_1753 | Clp protease/DnaK/DnaJ chaperone ATP-binding subunit | −3.28 |
| LCAZH_2207 | Molecular chaperone GroEL | −2.14 |
| LCAZH_2208 | Co-chaperonin GroES (HSP10) | −2.77 |
| LCAZH_2811 | Molecular chaperone | −5.1 |
| LCAZH_0348 | Thiamine monophosphate synthase | −2.21 |
| LCAZH_0739 | D-alanyl carrier protein | −3.1 |
| LCAZH_0852 | 50S ribosomal protein L14 | −2.21 |
| LCAZH_2835 | Amidase | −2.23 |
| LCAZH_1927 | Antimicrobial peptide ABC transporter permease | −2.34 |
| LCAZH_1928 | Antimicrobial peptide ABC transporter ATPase | −2.76 |
| LCAZH_1179 | XRE family transcriptional regulator | −4.68 |
| LCAZH_1052 | Hypothetical protein | −2.04 |
| LCAZH_1126 | Hypothetical protein | −2.01 |
| LCAZH_1754 | Hypothetical protein | −2.03 |
| LCAZH_0994 | Hypothetical protein | −2.06 |
| LCAZH_2341 | Prebacteriocin | −2.07 |
| LCAZH_0543 | Hypothetical protein | −2.1 |
| LCAZH_0824 | Hypothetical protein | −2.22 |
| LCAZH_1530 | Hypothetical protein | −2.23 |
| LCAZH_2528 | Hypothetical protein | −2.23 |
| LCAZH_1498 | Hypothetical protein | −2.24 |
| LCAZH_2472 | Hypothetical protein | −2.6 |
| LCAZH_1584 | Hypothetical protein | −2.85 |
| LCAZH_0616 | Hypothetical protein | −2.97 |
| LCAZH_0580 | Hypothetical protein | −3.06 |
| LCAZH_0521 | Hypothetical protein | −3.97 |
| LCAZH_2689 | Hypothetical protein | −4.46 |
| LCAZH_0113 | Hypothetical protein | −4.71 |
Figure 3The viable counts (A), pH values (B) and OD values (C) of the wild-type and mutant strains at the time of observing the minimum inhibitory concentration (MIC) by witness.